Ashwagandha extract sales will strengthen through 2035, anchored by powder at 57.0% share of the form segment in 2025. North America held 32.0% share of global demand in 2025. The market was valued at USD 815.7 million in 2025 and is projected to reach USD 1,787.2 million by 2035.